Abstract
Immune checkpoint inhibitors can lead to the development of organ and non-organ specific immune related adverse events.
Cite
CITATION STYLE
APA
Luu, Q., & Major, G. (2018). Unleashing the tiger – iatrogenic autoimmunity from cancer immunotherapy drugs. JRSM Open, 9(1), 205427041774690. https://doi.org/10.1177/2054270417746905
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free